This article was originally published in The Gray Sheet
Executive SummaryNational Institute for Clinical Excellence initiates review of wound care products July 21 focusing on "debriding agents in treating difficult to heal surgical wounds." The deadline for submissions is Oct. 4. The review is expected to produce treatment guidance for the UK's National Health Service
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.